C5ORF41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.542410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.079000E-01
Normal-vs-Stage2
1.676580E-01
Normal-vs-Stage3
1.144230E-01
Normal-vs-Stage4
6.850000E-01
Stage1-vs-Stage2
5.491400E-01
Stage1-vs-Stage3
1.377550E-01
Stage1-vs-Stage4
8.497600E-01
Stage2-vs-Stage3
1.958210E-01
Stage2-vs-Stage4
4.498000E-01
Stage3-vs-Stage4
1.627380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.311610E-01
Normal-vs-AfricanAmerican
6.368000E-01
Normal-vs-Asian
2.045000E-01
Caucasian-vs-AfricanAmerican
3.283600E-01
Caucasian-vs-Asian
5.670200E-01
AfricanAmerican-vs-Asian
3.527000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.556410E-01
Normal-vs-Female
1.756640E-01
Male-vs-Female
8.386600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.560000E-01
Normal-vs-Age(41-60Yrs)
4.223000E-01
Normal-vs-Age(61-80Yrs)
1.010180E-01
Normal-vs-Age(81-100Yrs)
2.599000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.599800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.678400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.884200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.741780E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.699520E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.623620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.522200E-02
Normal-vs-Daily Drinker
5.856000E-02
Normal-vs-Weekly Drinker
1.362180E-01
Normal-vs-Occasional Drinker
3.166000E-01
Normal-vs-Social Drinker
4.623800E-01
Non Drinker-vs-Daily Drinker
6.670400E-01
Non Drinker-vs-Weekly Drinker
8.190600E-01
Non Drinker-vs-Occasional Drinker
2.934000E-01
Non Drinker-vs-Social Drinker
2.046800E-01
Daily Drinker-vs-Weekly Drinker
9.066600E-01
Daily Drinker-vs-Occasional Drinker
1.786950E-01
Daily Drinker-vs-Social Drinker
1.331430E-01
Weekly Drinker-vs-Occasional Drinker
3.187400E-01
Weekly Drinker-vs-Social Drinker
2.569000E-01
Occasional Drinker-vs-Social Drinker
7.826400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.063600E-01
Normal-vs-Grade 2
3.884300E-02
Normal-vs-Grade 3
3.442000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.821840E-01
Grade 1-vs-Grade 3
1.941620E-01
Grade 1-vs-Grade 4
1.063600E-01
Grade 2-vs-Grade 3
9.115600E-01
Grade 2-vs-Grade 4
3.884300E-02
Grade 3-vs-Grade 4
3.442000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.688000E-02
Normal-vs-NonDiabetic
1.284180E-01
Diabetic-vs-NonDiabetic
8.697200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.265200E-01
Normal-vs-NoPancreatitis
1.459040E-01
Pancreatitis-vs-NoPancreatitis
1.802240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.718180E-01
Normal-vs-N1
1.723450E-01
N0-vs-N1
8.309800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.213200E-01
Normal-vs-TP53-NonMutant
3.747600E-01
TP53-Mutant-vs-TP53-NonMutant
9.093800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
